Circulating Supar in Two Cohorts of Primary FSGS

Total Page:16

File Type:pdf, Size:1020Kb

Circulating Supar in Two Cohorts of Primary FSGS CLINICAL RESEARCH www.jasn.org Circulating suPAR in Two Cohorts of Primary FSGS † ‡ Changli Wei,* Howard Trachtman, Jing Li,* Chuanhui Dong, Aaron L. Friedman,§ | | | Jennifer J. Gassman, June L. McMahan, Milena Radeva, Karsten M. Heil,¶ †† ‡‡ Agnes Trautmann,¶ Ali Anarat,** Sevinc Emre, Gian M. Ghiggeri, Fatih Ozaltin,§§ || ††† Dieter Haffner, Debbie S. Gipson,¶¶ Frederick Kaskel,*** Dagmar-Christiane Fischer, ‡‡‡ Franz Schaefer,¶ and Jochen Reiser, for the PodoNet and FSGS CT Study Consortia Departments of *Medicine and ‡Neurology, University of Miami Miller School of Medicine, Miami, Florida; †Department of Pediatrics, NYU Langone Medical Center, New York, New York; §Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota; |Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio; ¶Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany; **Department of Pediatric Nephrology, Cukurova University School of Medicine, Adana, Turkey; ††Department of Pediatrics, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey; ‡‡Division of Nephrology, Dialysis, and Transplantation, Laboratory on Pathophysiology of Uremia, G. Gaslini Children’s Hospital, Genoa, Italy; §§Pediatric Nephrology Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey; ||Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany; ¶¶Department of Pediatrics, University of Michigan, Ann Arbor, Michigan; ***Children’s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York; †††Department of Pediatrics, Rostock University Hospital, Rostock, Germany; and ‡‡‡Department of Medicine, Rush University Medical Center, Chicago, Illinois ABSTRACT Overexpression of soluble urokinase receptor (suPAR) causes pathology in animal models similar to pri- mary FSGS, and one recent study demonstrated elevated levels of serum suPAR in patients with the disease. Here, we analyzed circulating suPAR levels in two cohorts of children and adults with biopsy- proven primary FSGS: 70 patients from the North America–based FSGS clinical trial (CT) and 94 patients from PodoNet, the Europe-based consortium studying steroid-resistant nephrotic syndrome. Circulating suPAR levels were elevated in 84.3% and 55.3% of patients with FSGS patients in the CT and PodoNet cohorts, respectively, compared with 6% of controls (P,0.0001); inflammation did not account for this difference. Multiple regression analysis suggested that lower suPAR levels associated with higher esti- mated GFR, male sex, and treatment with mycophenolate mofetil. In the CT cohort, there was a positive association between the relative reduction of suPAR after 26 weeks of treatment and reduction of pro- teinuria, with higher odds for complete remission (P=0.04). In the PodoNet cohort, patients with an NPHS2 mutation had higher suPAR levels than those without a mutation. In conclusion, suPAR levels are elevated in geographically and ethnically diverse patients with FSGS and do not reflect a nonspecificproinflamma- tory milieu. The associations between a change in circulating suPAR with different therapeutic regimens and with remission support the role of suPAR in the pathogenesis of FSGS. J Am Soc Nephrol 23: 2051–2059, 2012. doi: 10.1681/ASN.2012030302 CLINICAL RESEARCH FSGS is an important cause of ESRD in children and – adults.1 3 It can occur as a primary disorder, conse- Received March 22, 2012. Accepted September 26, 2012. fi quent to genetic mutations in speci c podocyte pro- Published online ahead of print. Publication date available at teins, secondary to a wide range of medical problems, www.jasn.org. or as a consequence of adaptive changes to reduced Correspondence: Dr. Jochen Reiser, Department of Medicine, 4,5 . kidney mass. Intensive research for 50 years has Rush University Medical Center, 1735 W. Harrison Street, Cohn focused mainly on genetic, immunologic, and sys- Research Building, Suite 724, Chicago, IL 60612. Email: temic causes of FSGS but the cause of primary disease [email protected] remains elusive. Copyright © 2012 by the American Society of Nephrology J Am Soc Nephrol 23: 2051–2059, 2012 ISSN : 1046-6673/2312-2051 2051 CLINICAL RESEARCH www.jasn.org In recent years, there has been a great deal of investigation into the role of permeability factors in the pathogenesis of proteinuria and the development of primary FSGS. Proposed candidate molecules include hemopexin, vascular endothelial growth factor, and cardiotrophin-like cytokine-1.6–8 However, the detection of increased levels of most circulating perme- ability factors is generally not specific for a given glomerular disorder, and the activity or expression of these factors may be increased in patients with FSGS and minimal change ne- phrotic syndrome, two disorders with markedly disparate re- sponses to therapy and long-term prognosis.9 Soluble urokinase receptor (suPAR), the soluble form of urokinase plasminogen-type activator receptor, has been report- ed to be elevated in a number of diseases including cancer and infection in a nonspecific manner. However, its underlying mechanism of action in these conditions and its clinical value either in diagnosis or prognosis is still far from clear.10 Recently, Wei et al. reported the molecular identity of a putative perme- ability factor in FSGS.11 Approximately two-thirds of patients with primary FSGS had increased suPAR. Moreover, the circu- lating suPAR concentration was mostly normal in other forms of primary glomerular diseases including minimal change ne- phrotic syndrome, idiopathic membranous nephropathy, or preeclampsia.11 The investigators related the abnormal suPAR level to the pathogenesis of FSGS based on both in vitro and in Figure 1. Serum suPAR levels in distinct primary FSGS cohorts vivo studies, which demonstrated suPAR binding to and, more and control participants. ***P,0.001 for CT FSGS cohort versus importantly, activation of b3 integrin on podocytes. This inter- control, PodoNet FSGS cohort versus control, and CT versus action led to alterations in the morphology (foot process efface- PodoNet. Con, control. ment) and function of podocytes, which resulted in proteinuria and initiation of FSGS.11 The prevalence of elevated circulating suPAR levels in pa- was elevated in 84.3% of FSGS patients in the FSGS CT cohort tients with primary FSGS has not been systematically evalu- compared with 55.3% in the PodoNet cohort. The mean ated in any other large patient cohort. In addition, it is unclear suPAR level was higher in the FSGS CT cohort than in the if the circulating suPAR is modulated by immunosuppressive PodoNet cohort (45886203 versus 34976195 pg/ml; therapy. Therefore, in this report, we detail suPAR levels in P,0.0001). The mean serum creatinine was significantly two discrete well described cohorts of children and young adults higher in patients enrolled into the FSGS CT cohort than in with biopsy-proven primary FSGS—the North America–based PodoNet cohort, which might partially account for the differ- FSGS clinical trial (CT), and the Europe-based consortium for ence of suPAR between the two groups (see below). study of steroid-resistant nephrotic syndrome (PodoNet). C-Reactive Protein in FSGS Patients C-reactive protein (CRP) is an acute phase reactant that RESULTS increases 4–6hoursafteraninflammatory trigger, such as viral or bacterial infections. In most cases in which suPAR is pro- Elevated Circulating suPAR Levels in Distinct FSGS posed as a marker of inflammation, CRP and suPAR are pos- Cohorts itively correlated with each other.13,14 In parallel with the Circulating suPAR was measured in 150 control participants, suPAR measurements, serum CRP was determined to assess 70 patients with primary FSGS from the FSGS CT cohort, and the inflammatory status in a randomly selected subset of patients 94 patients with primary FSGS from PodoNet. Control par- from both the FSGS CT and PodoNet cohorts as well as in ticipants were age and sex matched for FSGS patients. Com- controls. The average CRP levels were generally low, indicating pared with control participants, the serum suPAR levels in minimal inflammation, and there was no difference between FSGS patients were markedly increased in both FSGS cohorts controls and FSGS patients (Figure 2A). This is consistent with (Figure 1). We set 3000 pg/ml as a cut-off value, which is based the classification of FSGS as a noninflammatory renal disease. on our own recent dataset11 as well as on a reported normal Moreover, there was no correlation between CRP and respec- mean serum suPAR level of 2710 pg/ml.12 Using 3000 pg/ml as tive suPAR levels in either controls (Figure 2B) or FSGS pa- a threshold level, the baseline circulating suPAR concentration tients (Figure 2C). In addition, serum samples from pediatric 2052 Journal of the American Society of Nephrology J Am Soc Nephrol 23: 2051–2059, 2012 www.jasn.org CLINICAL RESEARCH However, after 26 weeks of trial treatment, the mean suPAR level was significantly higher in patients assigned to CSA compared with the MMF arm (Figure 3A). When ex- amining the alteration from baseline to week 26, suPAR levels were increased in the CSA arm, but decreased in the MMF arm and the changes in suPAR levels between the two arms were significantly different (Figure 3B). These differences remained significant after controlling for age, sex, race, and the baseline levels of suPAR, eGFR, albumin, and Up/c (Table 3). With regard to the relationship
Recommended publications
  • Regulation of Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase (PDE1): Review
    95-105 5/6/06 13:44 Page 95 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 18: 95-105, 2006 95 Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review RAJENDRA K. SHARMA, SHANKAR B. DAS, ASHAKUMARY LAKSHMIKUTTYAMMA, PONNIAH SELVAKUMAR and ANURAAG SHRIVASTAV Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Cancer Research Division, Saskatchewan Cancer Agency, 20 Campus Drive, Saskatoon SK S7N 4H4, Canada Received January 16, 2006; Accepted March 13, 2006 Abstract. The response of living cells to change in cell 6. Differential inhibition of PDE1 isozymes and its environment depends on the action of second messenger therapeutic applications molecules. The two second messenger molecules cAMP and 7. Role of proteolysis in regulating PDE1A2 Ca2+ regulate a large number of eukaryotic cellular events. 8. Role of PDE1A1 in ischemic-reperfused heart Calmodulin-stimulated cyclic nucleotide phosphodiesterase 9. Conclusion (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems. Some PDE1 isozymes have similar kinetic and 1. Introduction immunological properties but are differentially regulated by Ca2+ and calmodulin. Accumulating evidence suggests that the A variety of cellular activities are regulated through mech- activity of PDE1 is selectively regulated by cross-talk between anisms controlling the level of cyclic nucleotides. These Ca2+ and cAMP signalling pathways. These isozymes are mechanisms include synthesis, degradation, efflux and seque- also further distinguished by various pharmacological agents. stration of cyclic adenosine 3':5'-monophosphate (cAMP) and We have demonstrated a potentially novel regulation of PDE1 cyclic guanosine 3':5'- monophosphate (cGMP) within the by calpain.
    [Show full text]
  • Kinase-Inactive ZAP-70 Thymocyte Development By
    An Improved Retroviral Gene Transfer Technique Demonstrates Inhibition of CD4− CD8− Thymocyte Development by Kinase-Inactive ZAP-70 This information is current as of September 23, 2021. Takehiko Sugawara, Vincenzo Di Bartolo, Tadaaki Miyazaki, Hiromitsu Nakauchi, Oreste Acuto and Yousuke Takahama J Immunol 1998; 161:2888-2894; ; http://www.jimmunol.org/content/161/6/2888 Downloaded from References This article cites 49 articles, 28 of which you can access for free at: http://www.jimmunol.org/content/161/6/2888.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. An Improved Retroviral Gene Transfer Technique Demonstrates Inhibition of CD42CD82 Thymocyte Development by Kinase-Inactive ZAP-701 Takehiko Sugawara,* Vincenzo Di Bartolo,§ Tadaaki Miyazaki,‡ Hiromitsu Nakauchi,* Oreste Acuto,§ and Yousuke Takahama2*† ZAP-70 is a Syk family tyrosine kinase that plays an essential role in initiating TCR signals.
    [Show full text]
  • A-Kinase Anchoring Protein–Calcineurin Signaling in Long-Term Depression of Gabaergic Synapses
    2650 • The Journal of Neuroscience, February 6, 2013 • 33(6):2650–2660 Cellular/Molecular A-Kinase Anchoring Protein–Calcineurin Signaling in Long-Term Depression of GABAergic Synapses Matthieu Dacher, Shawn Gouty, Steven Dash, Brian M. Cox, and Fereshteh S. Nugent Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 The postsynaptic scaffolding A-kinase anchoring protein 79/150 (AKAP79/150) signaling complex regulates excitatory synaptic trans- mission and strength through tethering protein kinase A (PKA), PKC, and calcineurin (CaN) to the postsynaptic densities of neurons (Sanderson and Dell’Acqua, 2011), but its role in inhibitory synaptic transmission and plasticity is unknown. Using immunofluorescence and whole-cell patch-clamp recording in rat midbrain slices, we show that activation of postsynaptic D2-like family of dopamine (DA) receptor in the ventral tegmental area (VTA) induces long-term depression (LTD) of GABAergic synapses on DA neurons through an inositol triphosphate receptor-mediated local rise in postsynaptic Ca 2ϩ and CaN activation accompanied by PKA inhibition, which requires AKAP150 as a bridging signaling molecule. Our data also illuminate a requirement for a clathrin-mediated internalization of GABAA receptors in expression of LTDGABA. Moreover, disruption of AKAP–PKA anchoring does not affect glutamatergic synapses onto DA neurons, suggesting that the PKA–AKAP–CaN complex is uniquely situated at GABAA receptor synapses in VTA DA neurons to regulate plasticity associated with GABAA receptors. Drug-induced modulation of GABAergic plasticity in the VTA through such novel signaling mechanisms has the potential to persistently alter the output of individual DA neurons and of the VTA, which may contribute to the reinforcing or addictive properties of drugs of abuse.
    [Show full text]
  • Soluble Epoxide Hydrolase Inhibition Protected Against Angiotensin II
    www.nature.com/scientificreports OPEN Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Received: 6 April 2017 Accepted: 29 June 2017 Remodeling Published online: 31 July 2017 Chi Zhou, Jin Huang, Qing Li, Jiali Nie, Xizhen Xu & Dao Wen Wang Epoxyeicosatrienoic acids (EETs), the metabolites of cytochrome P450 epoxygenases derived from arachidonic acid, exert important biological activities in maintaining cardiovascular homeostasis. Soluble epoxide hydrolase (sEH) hydrolyzes EETs to less biologically active dihydroxyeicosatrienoic acids. However, the efects of sEH inhibition on adventitial remodeling remain inconclusive. In this study, the adventitial remodeling model was established by continuous Ang II infusion for 2 weeks in C57BL/6 J mice, before which sEH inhibitor 1-trifuoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was administered by gavage. Adventitial remodeling was evaluated by histological analysis, western blot, immunofuorescent staining, calcium imaging, CCK-8 and transwell assay. Results showed that Ang II infusion signifcantly induced vessel wall thickening, collagen deposition, and overexpression of α-SMA and PCNA in aortic adventitia, respectively. Interestingly, these injuries were attenuated by TPPU administration. Additionally, TPPU pretreatment overtly prevented Ang II-induced primary adventitial fbroblasts activation, characterized by diferentiation, proliferation, migration, and collagen synthesis via Ca2+-calcineurin/NFATc3 signaling pathway in vitro. In summary, our results suggest that inhibition of sEH could be considered as a novel therapeutic strategy to treat adventitial remodeling related disorders. Aorta is composed of three tunicae: intima, media and adventitia. Te roles of intima and media on vascular functions have been extensively studied, while the contribution of adventitia to vascular functions was recently recognized.
    [Show full text]
  • Management of Steroid-Resistant Nephrotic Syndrome in Children and Adolescents
    Review Management of steroid-resistant nephrotic syndrome in children and adolescents Kjell Tullus, Hazel Webb, Arvind Bagga More than 85% of children and adolescents (majority between 1–12 years old) with idiopathic nephrotic syndrome Lancet Child Adolesc Health 2018 show complete remission of proteinuria following daily treatment with corticosteroids. Patients who do not show Published Online remission after 4 weeks’ treatment with daily prednisolone are considered to have steroid-resistant nephrotic October 17, 2018 syndrome (SRNS). Renal histology in most patients shows presence of focal segmental glomerulosclerosis, minimal http://dx.doi.org/10.1016/ S2352-4642(18)30283-9 change disease, and (rarely) mesangioproliferative glomerulonephritis. A third of patients with SRNS show mutations Nephrology Unit, Great in one of the key podocyte genes. The remaining cases of SRNS are probably caused by an undefined circulating Ormond Street Hospital for factor. Treatment with calcineurin inhibitors (ciclosporin and tacrolimus) is the standard of care for patients with Children, Great Ormond Street, non-genetic SRNS, and approximately 70% of patients achieve a complete or partial remission and show satisfactory London, UK (K Tullus MD, long-term outcome. Additional treatment with drugs that inhibit the renin–angiotensin axis is recommended for H Webb BSc) andDivision of Nephrology, Indian Council of hypertension and for reducing remaining proteinuria. Patients with SRNS who do not respond to treatment with Medical Research Advanced calcineurin inhibitors or other immunosuppressive drugs can show declining kidney function and are at risk for end- Center for Research in stage renal failure. Approximately a third of those who undergo renal transplantation show recurrent focal segmental Nephrology, All India Institute glomerulosclerosis in the allograft and often respond to combined treatment with plasma exchange, rituximab, and of Medical Sciences, New Delhi, India (Prof A Bagga MD) intensified immunosuppression.
    [Show full text]
  • Biol220 – Cellular Signalling
    Biol220 – Cellular Signalling Inositol Phospholipid Turnover and Ca2+ Signalling Calcium (Ca2+) as a signalling molecule Extracellular signals often cause a transient rise in the cytosolic [Ca2+]. In certain cells (e.g. neurones) the Ca2+ originates in the extracellular fluid; however, in many cells, the absence of Ca2+ in the extracellular fluid does not inhibit numerous Ca2+-mediated processes. Extracellular stimuli can provoke the release of Ca2+ from intracellular reservoirs (e.g. endoplasmic reticulum). This Ca2+ release must be mediated by an Visualization of Ca2+ in intracellular signal – cyclic nucleotides are not zebrafish embryos by involved. injecting them with aequorin; a photoprotein from the luminescent There is a correlation between mobilization of jellyfish that reacts with 2+ intracellular Ca and the turnover of Ca2+ and emits blue light phosphatidylinositol-4,5-bisphosphate, a minor at ~460 nm. component of the plasma membrane. Ca2+ signalling – the basics. The Phosphoinositide (PI) Signalling Pathway More than 25 different cell-surface receptors utilize the phosphoinositide (PI) signalling pathway. Adrenaline acting at 1-receptors, vasopressin acting at V1 receptors, and ADP and ATP acting at P2 receptors, all utilize this pathway to stimulate glycogen breakdown in the liver. Acetylcholine, acting through the PI pathway, stimulates amylase secretion from the pancreas. Thrombin stimulates aggregation of platelets through this pathway. Phospholipase C catalyzes the hydrolysis of PIP2 This reaction takes place in the plasma membrane and involves the breakdown of constituent phospholipids of the plasma membrane lipid bilayer. Between 2 and 8 % of the lipids of eukaryotic membranes are inositol-containing lipids. The three main forms are phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP) and phosphatidylinositol 4,5- bisphosphate (PIP2).
    [Show full text]
  • The Bitter Taste Receptor Tas2r14 Is Expressed in Ovarian Cancer and Mediates Apoptotic Signalling
    THE BITTER TASTE RECEPTOR TAS2R14 IS EXPRESSED IN OVARIAN CANCER AND MEDIATES APOPTOTIC SIGNALLING by Louis T. P. Martin Submitted in partial fulfilment of the requirements for the degree of Master of Science at Dalhousie University Halifax, Nova Scotia June 2017 © Copyright by Louis T. P. Martin, 2017 DEDICATION PAGE To my grandparents, Christina, Frank, Brenda and Bernie, and my parents, Angela and Tom – for teaching me the value of hard work. ii TABLE OF CONTENTS LIST OF TABLES ............................................................................................................. vi LIST OF FIGURES .......................................................................................................... vii ABSTRACT ....................................................................................................................... ix LIST OF ABBREVIATIONS AND SYMBOLS USED .................................................... x ACKNOWLEDGEMENTS .............................................................................................. xii CHAPTER 1 INTRODUCTION ........................................................................................ 1 1.1 G-PROTEIN COUPLED RECEPTORS ................................................................ 1 1.2 GPCR CLASSES .................................................................................................... 4 1.3 GPCR SIGNALING THROUGH G PROTEINS ................................................... 6 1.4 BITTER TASTE RECEPTORS (TAS2RS) ...........................................................
    [Show full text]
  • PLCE1 Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the Pkcα/NF-Κb Pathway
    Original Article Yonsei Med J 2018 Dec;59(10):1159-1165 https://doi.org/10.3349/ymj.2018.59.10.1159 pISSN: 0513-5796 · eISSN: 1976-2437 PLCE1 Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKCα/NF-κB Pathway Yongzhu Li and Chunyan Luan Department of Gastroenterology, Weifang Yidu Central Hospital, Weifang, Shandong, China. Purpose: To investigate the effect and mechanism of phospholipase C epsilon gene 1 (PLCE1) expression on esophageal cancer cell lines. Materials and Methods: The esophageal carcinoma cell lines Eca109 and EC9706 and normal esophageal epithelial cell line HEEC were cultured. The expression of PLCE1, protein kinase C alpha (PKCα), and nuclear factor kappa B (NF-κB) p50/p65 homodimer in cells were comparatively analyzed. The esophageal cancer cells were divided into si-PLCE1, control siRNA (scramble), and mock groups that were transfected with specific siRNA for PLCE1, control siRNA, and blank controls, respectively. Expression of PLCE1, PKCα, p50, and p65 was detected by Western blotting. Transwell assay was used to detect migration and invasion of Eca109 and EC9706 cells. Results: Compared with HEEC, the expression of PLCE1, PKCα, p50, and p65 was increased in Eca109 and EC9706 cells. The ex- pression of PLCE1 was positively correlated with the expression of PKCα and p50 (PKCα: r=0.6328, p=0.032; p50: r=0.6754, p=0.041). PKCα expression had a positive correlation with the expression of p50 and p65 (p50: r=0.9127, p=0.000; p65: r=0.9256, p=0.000). Down-regulation of PLCE1 significantly decreased the expression of PKCα and NF-κB-related proteins (p65: p=0.002, p=0.004; p50: p=0.005, p=0.009) and inhibited the migration and invasion of Eca109 and EC9706 cells.
    [Show full text]
  • Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis
    biomolecules Review Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis Robert M. Schilke y, Cassidy M. R. Blackburn y , Temitayo T. Bamgbose and Matthew D. Woolard * Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA; [email protected] (R.M.S.); [email protected] (C.M.R.B.); [email protected] (T.T.B.) * Correspondence: [email protected]; Tel.: +1-(318)-675-4160 These authors contributed equally to this work. y Received: 12 September 2020; Accepted: 13 October 2020; Published: 15 October 2020 Abstract: Phospholipases are a family of lipid-altering enzymes that can either reduce or increase bioactive lipid levels. Bioactive lipids elicit signaling responses, activate transcription factors, promote G-coupled-protein activity, and modulate membrane fluidity, which mediates cellular function. Phospholipases and the bioactive lipids they produce are important regulators of immune cell activity, dictating both pro-inflammatory and pro-resolving activity. During atherosclerosis, pro-inflammatory and pro-resolving activities govern atherosclerosis progression and regression, respectively. This review will look at the interface of phospholipase activity, immune cell function, and atherosclerosis. Keywords: atherosclerosis; phospholipases; macrophages; T cells; lipins 1. Introduction All cellular membranes are composed mostly of phospholipids. Phospholipids are amphiphilic compounds with a hydrophilic, negatively charged phosphate group head and two hydrophobic fatty acid tail residues [1]. The glycerophospholipids, phospholipids with glycerol backbones, are the largest group of phospholipids, which are classified by the modification of the head group [1]. The negatively charged phosphate head forms an ionic bond with an amino alcohol. This bridges the glycerol backbone to the nitrogenous functional group (amino alcohol).
    [Show full text]
  • Activation of Phospholipase C Pathways by a Synthetic Chondroitin Sulfate-E Tetrasaccharide Promotes Neurite Outgrowth of Dopaminergic Neurons
    Journal of Neurochemistry, 2007, 103, 749–760 doi:10.1111/j.1471-4159.2007.04849.x Activation of phospholipase C pathways by a synthetic chondroitin sulfate-E tetrasaccharide promotes neurite outgrowth of dopaminergic neurons Naoki Sotogaku,* Sarah E. Tully, Cristal I. Gama, Hideho Higashi,à Masatoshi Tanaka,* Linda C. Hsieh-Wilson and Akinori Nishi* *Department of Pharmacology, Kurume University School of Medicine, Kurume, Fukuoka, Japan Division of Chemistry and Chemical Engineering and Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California, USA àDepartment of Physiology, Kurume University School of Medicine, Kurume, Fukuoka, Japan Abstract of the molecular mechanisms revealed that the action of the In dopaminergic neurons, chondroitin sulfate (CS) proteogly- CS-E tetrasaccharide was mediated through midkine-pleio- cans play important roles in neuronal development and trophin/protein tyrosine phosphatase f and brain-derived regeneration. However, due to the complexity and heteroge- neurotrophic factor/tyrosine kinase B receptor pathways, neity of CS, the precise structure of CS with biological activity followed by activation of the two intracellular phospholipase C and the molecular mechanisms underlying its influence on (PLC) signaling cascades: PLC/protein kinase C and PLC/ dopaminergic neurons are poorly understood. In this study, we inositol 1,4,5-triphosphate/inositol 1,4,5-triphosphate receptor investigated the ability of synthetic CS oligosaccharides and signaling leading to intracellular Ca2+
    [Show full text]
  • USP16-Mediated Deubiquitination of Calcineurin a Controls Peripheral T Cell Maintenance
    USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance Yu Zhang, … , Yi-yuan Li, Jin Jin J Clin Invest. 2019;129(7):2856-2871. https://doi.org/10.1172/JCI123801. Research Article Cell biology Immunology Graphical abstract Find the latest version: https://jci.me/123801/pdf RESEARCH ARTICLE The Journal of Clinical Investigation USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance Yu Zhang,1,2 Rong-bei Liu,2 Qian Cao,2 Ke-qi Fan,1 Ling-jie Huang,2 Jian-shuai Yu,1 Zheng-jun Gao,1 Tao Huang,1 Jiang-yan Zhong,1 Xin-tao Mao,1 Fei Wang,1 Peng Xiao,2 Yuan Zhao,2 Xin-hua Feng,1 Yi-yuan Li,1 and Jin Jin1,2,3 1MOE Key Laboratory of Biosystems Homeostasis and Protection, Life Sciences Institute, Zhejiang University, Hangzhou, China. 2Sir Run Run Shaw Hospital, College of Medicine Zhejiang University, Hangzhou, China. 3Key Laboratory of Animal Virology of Ministry of Agriculture, Zhejiang University, Hangzhou, China. Calcineurin acts as a calcium-activated phosphatase that dephosphorylates various substrates, including members of the nuclear factor of activated T cells (NFAT) family, to trigger their nuclear translocation and transcriptional activity. However, the detailed mechanism regulating the recruitment of NFATs to calcineurin remains poorly understood. Here, we report that calcineurin A (CNA), encoded by PPP3CB or PPP3CC, is constitutively ubiquitinated on lysine 327, and this polyubiquitin chain is rapidly removed by ubiquitin carboxyl-terminal hydrolase 16 (USP16) in response to intracellular calcium stimulation. The K29-linked ubiquitination of CNA impairs NFAT recruitment and transcription of NFAT-targeted genes.
    [Show full text]
  • Insights Derived from the Structures of the Ser/Thr Phosphatases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector DL LOHSE, JM DENU AND JE DIXON MINIREVIEW Insights derived from the structures of the Ser/Thr phosphatases calcineurin and protein phosphatase 1 The crystal structures of serine/threonine phosphatases provide the basis for understanding their inhibition by physiologically relevant compounds such as microcystin, cyclosporin and FK506. The structures also highlight the importance of a common sequence motif found in a large family of metal-containing enzymes involved in phosphate ester hydrolysis. Structure 15 October 1995, 3:987-990 There are numerous enzymes capable of hydrolyzing Structural features of the PPases phosphate esters [1]. The non-specific alkaline and acid The central feature of the structure of PPase-1 reported by phosphatases serve to recycle phosphate in metabolic Goldberg et al. [13] is the positioning of two metal ions by a reactions, and the protein phosphatases regulate signal- central 3-a-3---13 scaffold (Fig. la). These two metal ions transduction pathways. The protein phosphatases have appear to play both structural and catalytic roles in the phos- been divided into two large families on the basis of their phatases. The amino-acid residues highlighted in Figure lb substrate specificity. The family of protein-tyrosine are found at the intervening loops of this scaffold and phosphatases (PTPases) shows a preference for removing converge at the active site to participate in substrate recogni- phosphate from tyrosine and requires no metal ions for tion, to bind metal ions and to contribute to catalysis.
    [Show full text]